miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 15, 2012, Pages 5826-5831

  Guo, Zhong ^a   Shao, Lifang ^a   Zheng, Liang ^b   Du, Qiang ^a   Li, Peiyuan ^a   John, Bino ^b   Geller, David A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

miRNA regulation; Nitric oxide

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LUCIFERASE; MICRORNA; MICRORNA 939; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LIVER CELL; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN BINDING; REPORTER GENE; RNA TRANSLATION; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; BINDING SITES; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICRORNAS; MUTAGENESIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

MUS;

EID: 84859563249     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1118118109     Document Type: Article

References (41)

1. Ignarro L-J, et al. (2001) Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 98:4202-4208.
2. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012. (Pubitemid 24015045)
3. Napoli C, Ignarro L-J (2009) Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 32:1103-1108.
4. Lowenstein C-J, Glatt C-S, Bredt D-S, Snyder S-H (1992) Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 89:6711-6715.
5. Lowenstein C-J, et al. (1993) Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90:9730-9734.
6. Stuehr D-J, Marletta M-A (1985) Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 82:7738-7742.
7. Geller D-A, et al. (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90:3491-3495.
8. de Vera M-E, et al. (1996) Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 93:1054-1059.
9. Taylor BS, et al. (1998) Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273:15148-15156. (Pubitemid 28272813)
10. Ganster R-W, Taylor B-S, Shao L, Geller D-A (2001) Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci USA 98:8638-8643. (Pubitemid 32678080)
11. Feng X, et al. (2002) Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene. Proc Natl Acad Sci USA 99:14212-14217. (Pubitemid 35257651)
12. Guo Z, et al. (2003) A critical role for C/EBPbeta binding to the AABS promoter response element in the human iNOS gene. FASEB J 17:1718-1720.
13. Warke V-G, et al. (2003) Transcriptional activation of the human inducible nitric-oxide synthase promoter by Kruppel-like factor 6. J Biol Chem 278:14812-14819.
14. Kröncke K-D, Fehsel K, Kolb-Bachofen V (1998) Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113:147-156. (Pubitemid 28352831)
15. Kristof A-S, Marks-Konczalik J, Moss J (2001) Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J Biol Chem 276:8445-8452.
16. Chu S-C, Marks-Konczalik J, Wu H-P, Banks T-C, Moss J (1998) Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: Characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun 248:871-878. (Pubitemid 28404515)
17. Rodriguez-Pascual F, et al. (2000) Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J Biol Chem 275:26040-26049.
18. Korhonen R, et al. (2007) Post-transcriptional regulation of human inducible nitricoxide synthase expression by the Jun N-terminal kinase. Mol Pharmacol 71:1427-1434. (Pubitemid 46658695)
19. Pautz A, et al. (2006) The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression. J Biol Chem 281:32294-32302. (Pubitemid 46036783)
20. Linker K, et al. (2005) Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res 33:4813-4827. (Pubitemid 41418881)
21. Chan G-C, et al. (2005) Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J Immunol 175:3846-3861.
22. Luss H, et al. (1997) Dedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFNgamma, and LPS. J Mol Cell Cardiol 29:1153-1165. (Pubitemid 27211896)
23. John B, et al. (2005) Human microRNA targets. PLoS Biol 10:1371.
24. Zeng Y, Yi R, Cullen B-R (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA 100:9779-9784. (Pubitemid 37087018)
25. Bloomston M, et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297:1901-1908. (Pubitemid 46707844)
26. Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M (2008) MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 12:2171-2176.
27. Calin G-A, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999-3004.
28. Jenkins D-C, et al. (1995) Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92:4392-4396.
29. Jenkins D-C, et al. (1994) Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 70:847-849.
30. Suschek C-V, Schnorr O, Kolb-Bachofen V (2004) The role of iNOS in chronic inflammatory processes in vivo: Is it damage-promoting, protective, or active at all? Curr Mol Med 4:763-775. (Pubitemid 39369294)
31. Du Q, et al. (2006) Regulation of human NOS2 expression by wnt b-catenin signaling. Cancer Res 66:7024-7031. (Pubitemid 44197678)
32. Du Q, et al. (2009) Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res 69:3764-3771.
33. Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP (2003) Vertebrate microRNA genes. Science 299:1540. (Pubitemid 36297696)
34. Iwasaki S, Tomari Y (2009) Argonaute-mediated translational repression (and activation). Fly (Austin) 3:204-206.
35. Hammell C-M (2008) The microRNA-argonaute complex: A platform for mRNA modulation. RNA Biol 5:123-127.
36. Pautz A, et al. (2010) Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23:75-93.
37. Dai R, et al. (2008) Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: A novel mechanism of immune modulation. Blood 112:4591-4597.
38. Wang X, et al. (2009) Inducible nitric-oxide synthase expression is regulated by mitogen-activated protein kinase phosphatase-1. J Biol Chem 284:27123-27134.
39. Zeng Y, Cullen B-R (2003) Sequence requirements for micro RNA processing and function in human cells. RNA 9:112-123. (Pubitemid 36206307)
40. Lui W-O, Pourmand N, Patterson B-K, Fire A (2007) Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67:6031-6043. (Pubitemid 47037482)
41. Liu H, Song L, Huang W (2010) MiR26a and miR939 regulate the replication of H1N1 influenza virus in MDCK cell. Wei Sheng Wu Xue Bao 50:1399-1405.